XML 41 R35.htm IDEA: XBRL DOCUMENT v3.24.3
Stock-based Compensation (Tables)
9 Months Ended
Oct. 31, 2024
Share-Based Payment Arrangement [Abstract]  
Classification of Stock-based Compensation

The following table presents the classification of stock-based compensation for the periods indicated:

 

 

 

Three Months Ended October 31,

 

 

Nine Months Ended October 31,

 

 

 

2024

 

 

2023

 

 

2024

 

 

2023

 

 

 

(in thousands)

 

Stock-based compensation:

 

 

 

 

 

 

 

 

 

 

 

 

Cost of revenue

 

$

899

 

 

$

868

 

 

$

2,339

 

 

$

2,694

 

Research and development

 

 

18,637

 

 

 

17,898

 

 

 

54,653

 

 

 

54,809

 

Selling, general and administrative

 

 

7,311

 

 

 

8,643

 

 

 

23,503

 

 

 

25,293

 

Total stock-based compensation

 

$

26,847

 

 

$

27,409

 

 

$

80,495

 

 

$

82,796

 

Weighted-Average Assumptions Used to Estimate Fair Value

The following table sets forth the weighted-average assumptions used to estimate the fair value of employee stock purchase plan awards for the periods indicated:

 

 

 

Three Months Ended October 31,

 

 

Nine Months Ended October 31,

 

 

 

2024

 

 

2023

 

 

2024

 

 

2023

 

Employee stock purchase plan awards:

 

 

 

 

 

 

 

 

 

 

 

 

Volatility

 

 

56

%

 

 

54

%

 

 

47

%

 

 

56

%

Risk-free interest rate

 

 

4.55

%

 

 

5.49

%

 

 

4.97

%

 

 

5.11

%

Expected term (years)

 

0.5

 

 

0.5

 

 

0.5

 

 

0.5

 

Dividend yield

 

 

0

%

 

 

0

%

 

 

0

%

 

 

0

%

Stock Option Activities

The following table summarizes stock option activities for the period indicated:

 

 

 

Options Outstanding

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Weighted-

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Total Intrinsic

 

 

Average

 

 

 

 

 

 

 

 

 

 

 

 

Weighted-

 

Value Of

 

 

Remaining

 

 

Aggregate

 

 

 

 

 

 

Weighted-

 

 

Average

 

Options

 

 

Contractual

 

 

Intrinsic

 

 

 

 

 

 

Average

 

 

Grant-date

 

Exercised

 

 

Term

 

 

Value

 

 

 

Shares

 

 

Exercise Price

 

 

Fair Value

 

(in thousands)

 

 

(in years)

 

 

(in thousands)

 

Outstanding at January 31, 2024

 

 

373,318

 

 

$

46.39

 

 

 

 

 

 

 

 

 

 

 

 

Exercised

 

 

(105,890

)

 

 

37.59

 

 

 

 

$

1,705

 

 

 

 

 

 

 

Forfeited

 

 

(63

)

 

 

111.50

 

 

 

 

 

 

 

 

 

 

 

 

Expired

 

 

(1,425

)

 

 

50.93

 

 

 

 

 

 

 

 

 

 

 

 

Outstanding at October 31, 2024

 

 

265,940

 

 

 

49.86

 

 

 

 

 

 

 

 

3.64

 

 

$

2,883

 

Exercisable at October 31, 2024

 

 

246,289

 

 

$

51.26

 

 

 

 

 

 

 

 

3.45

 

 

$

2,377

 

Restricted Stock Unit Activities

The following table summarizes restricted stock unit activities for the period indicated:

 

 

 

 

 

 

Weighted-

 

 

 

 

 

 

Average

 

 

 

 

 

 

Grant-Date

 

 

 

Shares

 

 

Fair Value

 

Unvested at January 31, 2024

 

 

2,432,640

 

 

$

82.54

 

Granted

 

 

1,431,816

 

 

 

62.12

 

Vested

 

 

(851,932

)

 

 

75.81

 

Forfeited

 

 

(151,000

)

 

 

118.07

 

Unvested at October 31, 2024

 

 

2,861,524

 

 

$

72.45